Company / Interest Expense per Share
Eton Pharmaceuticals, Inc. Interest Expense per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense per Share
$0.04
FY2025
5-year range
$0.00 / $0.04
FY2021-FY2025
Trend
+9.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Interest Expense per Share has fluctuated over the past 6 years, ranging from $0.00 in FY2021 to $0.04 in FY2023.
Based on SEC 10-K filings.
0.04 in FY2025 with a 5-year CAGR of +49.7%.
Improved from $0.04 to $0.04 over the past 2 years.
Interest Expense per Share over time
Growth rates
- 3-Year CAGR
- +4.8%
- 5-Year CAGR
- +49.7%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, interest expense per share increased 9.5% year-over-year.
- Peak interest expense per share was recorded in FY2023.
- Lowest interest expense per share in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score 0.63 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest Expense per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.04 | +9.5% |
| FY2024 | $0.04 | -12.1% |
| FY2023 | $0.04 | +19.4% |
| FY2022 | $0.04 | +790.6% |
| FY2021 | $0.00 | -26.5% |
| FY2020 | $0.01 | - |
| FY2019 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026